Emerging Insights into Targeted Therapy-Tolerant Persister Cells in Cancer is a research paper published in Cancers (2021). On theSindex it has a DataRank of 0. It has been cited 192 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: K08 CA197389
National Institutes of Health
Grant: R01 CA137008
Doris Duke Charitable Foundation
Grant: Clinical Scientist Development Award
Stand Up To Cancer
Grant: Convergence 1.0 Team Award
V Foundation
Grant: Scholar Award
Ludwig Center at Harvard
Grant: N/A
National Institutes of Health
Grant: 2R01CA137008-06
Impact of heterogeneity on response to EGFR T790M inhibitors
National Institutes of Health
Grant: 5K08CA197389-02
Evolution of resistance of EGFR mutant non-small cell lung cancer
FWCI
11.16
Citation Percentile
1.0%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals